A recent study using genome-wide CRISPR screening in DLBCL cell lines has identified critical positive and negative regulators of MHC-I expression, among which EZH2 is the most crucial one in GCB-DLBCL (Dersh et al., 2021). Here, EZH2 is linked to diffuse large B-cell lymphoma.